Degradable poly(2-hydroxyethyl methacrylate)-co-polycaprolactone hydrogels for tissue engineering scaffolds.

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Tissue Engineering

Background:

• Hydrogels are ideal for tissue engineering scaffolds due to their mechanical and mass transfer properties.
• Existing hydrogels often lack biodegradability, hindering their clearance from the body.
• Poly(2-hydroxyethyl methacrylate) (pHEMA) offers good mechanical strength, elasticity, and a history of safe medical use.

Purpose of the Study:

• To develop biodegradable pHEMA hydrogels for engineered tissue constructs.
• To incorporate tunable degradation rates into pHEMA scaffolds.
• To assess the suitability of these hydrogels for tissue engineering applications.

Main Methods:

• Utilized atom transfer radical polymerization (ATRP) with a degradable cross-linker and macroinitiator.
• Incorporated polycaprolactone (PCL) blocks for hydrolytic and enzymatic degradability.
• Characterized hydrogel properties including molecular weight, chain length, cross-link density, and mechanical properties.
• Evaluated degradation via mass loss, swelling ratio, and tensile modulus in NaOH, lipase, and PBS solutions.

Main Results:

• pHEMA hydrogels with varying molecular weights (2-50 kDa) were successfully synthesized.
• Mechanical properties were influenced by chain length, cross-link density, and solvent.
• Bulk degradation was observed in all polycaprolactone-containing samples, with 30% mass loss in 16 weeks in enzymatic solutions.
• No adverse cellular response was noted in initial toxicity studies.

Conclusions:

• Developed biodegradable pHEMA hydrogels possess tunable degradation and appropriate mechanical properties.
• The materials are derived from FDA-approved components, enhancing their clinical potential.
• These hydrogels show significant promise as scaffolds for cardiac and other tissue engineering applications.